Please login or register first to view this content.
Oncology Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
- Bladder, kidney, and other urologic cancers
- Bone and connective tissue cancer
- Breast cancer
- CNS cancer
- Colorectal and other GI cancers
- Cytoprotective and supportive care agents
- Eye cancer
- Gynecologic cancer
- Head and neck cancer
- Kaposi’s sarcoma
- Leukemias, lymphomas, and other hematologic cancers
- Melanoma and other skin cancers
- Pancreatic, thyroid, and other endocrine cancers
- Prostate and other male cancers
- Respiratory and thoracic cancers
NEWS & FEATURES
ATA Issues Guidelines for Managing Anaplastic Thyroid Cancer
Opdivo Plus Chemotherapy Approved for First-Line Treatment of Gastric Cancer
Trodelvy Gets Accelerated Approval for Urothelial Cancer
ACG Updates Guidelines for Colorectal Cancer Screening
AACR: Copanlisib + Rituximab Slows Relapsed Indolent Lymphoma
Tisotumab Vedotin Under Review for Recurrent or Metastatic Cervical Cancer
FDA Clears AI System to Detect Lesions During Colonoscopy
Changes in Cancer Incidence, Deaths Expected by 2040
Diet, Exercise Intervention Explored in Children With B-ALL
FDA Grants Full Approval to Trodelvy for Triple-Negative Breast Cancer
New Dosing Regimen Approved for Erbitux in Colorectal, Head and Neck Cancer
Tislelizumab Plus Chemo Slows Advanced Squamous NSCLC
Adjuvant Nivolumab Beneficial in Esophageal, GE Junction Cancer
FDA: Complications Up for 2 Brands of Surgical Mesh Used in Breast Reconstruction
Sarclisa Plus Carfilzomib and Dexamethasone Approved for Relapsed/Refractory Multiple Myeloma
FDA Approves Vyxeos for Secondary Acute Myeloid Leukemia in Pediatric Patients
Abecma Approved for Relapsed/Refractory Multiple Myeloma
FDA-Approved VEGFR Tyrosine Kinase Inhibitors Ranked by Cardiotoxic Potential
